Key result
Cryoablation using an 8 mm-tip catheter was comparable to radiofrequency ablation for AVNRT, with recurrences in 3.8% (3/80) vs 1.3% (1/79) of patients, though long-term efficacy remains unresolved.
Why the study?
Does cryoablation with an 8 mm-tip catheter improve safety and efficacy compared to radiofrequency ablation in patients with AVNRT?
Does cryoablation with an 8 mm-tip catheter improve safety and efficacy compared to radiofrequency ablation in patients with AVNRT?
Answers are grounded in this paper and cite their sources.
This editorial concludes that 8-mm tip cryoablation does not offer a credible advantage over radiofrequency ablation for AVNRT in adults, citing concerns over recurrence trends, troponin release, and catheter size.
This editorial refers to ‘Cryoablation with an 8-mm tip catheter in the treatment of atrioventricular nodal re-entrant tachycardia: results from a randomized controlled trial (CRYOABLATE)’ by N.-Y. Chan et al., on pages 662–669. Catheter ablation is now established as the therapy of choice in patients with symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT).1,2 Slow pathway modification using radiofrequency energy (RF) is effective in both typical and atypical AVNRT,3 offers a success rate of 95% with an approximately 1.3–4% recurrence rate in patients without congenital heart disease, and, in previous reports, has been associated with a risk of atrioventricular (AV) block <1%.4–6 Cryoablation is an alternative energy mode that due to its immediate reversibility during the procedure may carry a lower risk of AV block, thus being especially attractive in children.7 However, a significantly higher recurrence rate compared to RF has been shown in both randomized comparisons and descriptive reports.8–11 All these results have been derived with the use of 4 mm- or 6 mm-tip catheters for cryoablation. In this issue of EP-Europace, Chan et al.12 report on the first randomized comparison between RF and cryoablation using an 8 mm-tip catheter. The 8 mm-tip catheter cryoablation was comparable to RF in terms of efficacy, with no permanent inadvertent AV block, and with the additional advantages of shorter fluoroscopic time, lower patient pain perception and operator stress level. The authors are to be commented for this important trial. However, what are the clinical implications? Is this new mode of therapy the next step for AVNRT ablation? There are several caveats and obscure points that have to be addressed before reaching such a conclusion. First, the main advantage of cryoablation is its safety regarding inadvertent AV block. However, recent experience indicates that the procedure can be accomplished using RF in both typical and atypical AVNRT by targeting the inferior nodal extension with no risk of AV block.3,13 As we get more insight into the mysteries of the circuit of this fascinating arrhythmia,14,15 we improve our ablation approach. We now know that the nodal extensions at the inferior (posterior) part of the triangle of Koch and below the coronary sinus ostium as depicted in the right anterior oblique projection, is the appropriate target for successful ablation either from the right or the left septum. Higher lesions are not necessary, and are potentially dangerous by means of damaging the AV node.1,3,13,16 Second, elimination of the slow pathway with the absence of an anterograde conduction jump, as recommended by Chan et al., is not a required endpoint for successful ablation anymore.14 Inappropriately extensive application of lesions may be responsible for the increased (8 times higher compared to that after RF) troponin release documented following cryoablation in this trial. Third, despite the lack of statistical significance that may well be due to the limited power of the study, 3 out of 80 patients in the cryoablation group as compared to 1 out of 79 patients in the RF group had a recurrence. Thus, the issue of long-term efficacy of the 8 mm-tip catheter is not yet resolved in my view. Further, in contrast to 4 mm- or 6 mm-tip catheters, cryomapping using the temperature plateau feature is not available in the 8 mm-tip cryocatheter, allowing additional concerns about the actual safety of this procedure. Last, but not least, the 8 mm-tip cryocatheter is 9-Fr in size and requires a 10-Fr femoral venous for insertion. If the main indication of cryoablation is the paediatric population, this size clearly represents a serious disadvantage of the method. In conclusion, I believe that in the current era, cryoablation does not offer any credible advantage over RF, at least in the adult population. It can be tried in children, depending on the experience of the operator, but at the expense of an increased risk of tachycardia recurrence and need for a repeat procedure. Whether the 8 mm-tip catheter produces better results that its 4 mm- and 6 mm-tip equivalents remains to be seen. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Demosthenes G. Katritsis (2018) conducted an editorial in Atrioventricular nodal re-entrant tachycardia (AVNRT) (n=159). Cryoablation (8 mm-tip catheter) vs. Radiofrequency ablation was evaluated on Tachycardia recurrence. Cryoablation using an 8 mm-tip catheter was comparable to radiofrequency ablation for AVNRT, with recurrences in 3.8% (3/80) vs 1.3% (1/79) of patients, though long-term efficacy remains unresolved.
Synapse has enriched 10 related papers. Consider them for comparative context: